Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.
John BoyagesFrank A ViciniBehnaz Azimi ManaviRichelle L GawLouise A KoelmeyerSheila H RidnerChriag S ShahPublished in: JCO oncology practice (2023)
The extent of axillary treatment is a significant risk factor for cBCRL. Increasing BMI, rurality, SCF radiation, and taxane chemotherapy also increase risk. These results have implications for a proposed risk-based lymphedema screening, early intervention, and treatment program.